The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Specific SSRIs and birth defects: bayesian analysis to interpret new data in the context of previous reports
Open accessAbstract
OBJECTIVE: To follow up on previously reported associations between periconceptional use of selective serotonin reuptake inhibitors (SSRIs) and specific birth defects using an expanded dataset from the National Birth Defects Prevention Study. DESIGN: Bayesian analysis combining results from independent published analyses with data from a multicenter population based case-control study of birth defects. SETTING: 10 centers in the United States. PARTICIPANTS: 17,952 mothers of infants with birth defects and 9857 mothers of infants without birth defects, identified through birth certificates or birth hospitals, with estimated dates of delivery between 1997 and 2009. EXPOSURES: Citalopram, escitalopram, fluoxetine, paroxetine, or sertraline use in the month before through the third month of pregnancy. Posterior odds ratio estimates were adjusted to account for maternal race/ethnicity, education, smoking, and prepregnancy obesity. MAIN OUTCOME MEASURE: 14 birth defects categories that had associations with SSRIs reported in the literature. RESULTS: Sertraline was the most commonly reported SSRI, but none of the five previously reported birth defects associations with sertraline was confirmed. For nine previously reported associations between maternal SSRI use and birth defect in infants, findings were consistent with no association. High posterior odds ratios excluding the null value were observed for five birth defects with paroxetine (anencephaly 3.2, 95% credible interval 1.6 to 6.2; atrial septal defects 1.8, 1.1 to 3.0; right ventricular outflow tract obstruction defects 2.4, 1.4 to 3.9; gastroschisis 2.5, 1.2 to 4.8; and omphalocele 3.5, 1.3 to 8.0) and for two defects with fluoxetine (right ventricular outflow tract obstruction defects 2.0, 1.4 to 3.1 and craniosynostosis 1.9, 1.1 to 3.0). CONCLUSIONS: These data provide reassuring evidence for some SSRIs but suggest that some birth defects occur 2-3.5 times more frequently among the infants of women treated with paroxetine or fluoxetine early in pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, the risk of birth defects seems to be increased in infants of women treated with some SSRIs during pregnancy.51”
From Should antidepressants be used for major depressive disorder? (2020) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No adjustments are needed for multiple comparisons.
Rothman, K. J. (1990) · Epidemiology · doi:10.1097/00001648-199001000-00010 · Cited by 5,965
Parker, S. E., Mai, C. T., Canfield, M. A., Rickard, R., Wang, Y., Meyer, R. E., Anderson, P., Mason, C. A., Collins, J. S., Kirby, R. S., et al. (2010) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20735 · Cited by 1,887
Philosophy and the practice of Bayesian statistics
Gelman, A., & Shalizi, C. R. (2013) · British Journal of Mathematical and Statistical Psychology · doi:10.1111/j.2044-8317.2011.02037.x · Cited by 825
Bayesian methods in meta-analysis and evidence synthesis
Sutton, A. J., & Abrams, K. R. (2001) · Statistical Methods in Medical Research · doi:10.1177/096228020101000404 · Cited by 734
Philosophy and the practice of Bayesian statistics
Gelman, A., & Shalizi, C. R. (2010) · Cited by 709
The National Birth Defects Prevention Study
Yoon, P., Rasmussen, S., Lynberg, M. C., Moore, C., Anderka, M., Carmichael, S. L., Costa, P., Druschel, C. M., Hobbs, C., Romitti, P., et al. (2001) · Public Health Reports · doi:10.1093/phr/116.s1.32 · Cited by 696
Diabetes mellitus and birth defects
Correa, A., Gilboa, S. M., Besser, L. M., Botto, L. D., Moore, C. A., Hobbs, C. A., Cleves, M. A., Riehle‐Colarusso, T. J., Waller, D. K., & Reece, E. A. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.06.028 · Cited by 692
Guidelines for case classification for the national birth defects prevention study
Rasmussen, S. A., Olney, R. S., Holmes, L. B., Lin, A. E., Keppler‐Noreuil, K. M., & Moore, C. A. (2003) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.10012 · Cited by 581
The BUGS Book: A Practical Introduction to Bayesian Analysis
Lunn, D. J., Jackson, C. H., Best, N., Thomas, A. C., & Spiegelhalter, D. J. (2012) · Cited by 530
Women’s Attitudes, Preferences, and Perceived Barriers to Treatment for Perinatal Depression
Goodman, J. H. (2009) · Birth · doi:10.1111/j.1523-536x.2008.00296.x · Cited by 526
Cited by
Sorted by citations
Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447034 · Cited by 650
Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review
Edinoff, A. N., Akuly, H. A., Hanna, T. A., Ochoa, C. O., Patti, S. J., Ghaffar, Y. T., Kaye, A. D., Viswanath, O., Urits, I., Boyer, A. G., et al. (2021) · Neurology International · doi:10.3390/neurolint13030038 · Cited by 506
Etiology and clinical presentation of birth defects: population based study
Feldkamp, M. L., Carey, J. C., Byrne, J. L. B., Krikov, S. V., & Botto, L. D. (2017) · BMJ · doi:10.1136/bmj.j2249 · Cited by 245
Nillni, Y. I., Mehralizade, A., Mayer, L., & Milanovic, S. (2018) · Clinical Psychology Review · doi:10.1016/j.cpr.2018.06.004 · Cited by 207
Should antidepressants be used for major depressive disorder?
Jakobsen, J. C., Gluud, C., & Kirsch, I. (2020) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2019-111238 · Cited by 162
S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders
Sharma, A. K., Gerbarg, P. L., Bottiglieri, T., Massoumi, L., Carpenter, L. L., Lavretsky, H., Muskin, P. R., Brown, R. P., & Mischoulon, D. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16r11113 · Cited by 158
Use of real‐world evidence from healthcare utilization data to evaluate drug safety during pregnancy
Huybrechts, K. F., Bateman, B. T., & Hernández–Dı́az, S. (2019) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4789 · Cited by 162
Gao, S.-Y., Wu, Q.-J., Sun, C., Zhang, T.-N., Shen, Z.-Q., Liu, C.-X., Gong, T.-T., Xu, X., Ji, C., Huang, D.-H., et al. (2018) · BMC Medicine · doi:10.1186/s12916-018-1193-5 · Cited by 152
The GABAergic Hypothesis for Cognitive Disabilities in Down Syndrome
Contestabile, A., Magara, S., & Cancedda, L. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00054 · Cited by 141
Anderson, K. N., Lind, J. N., Simeone, R. M., Bobo, W. V., Mitchell, A. A., Riehle‐Colarusso, T. J., Polen, K. N. D., & Reefhuis, J. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.2453 · Cited by 146
Self-citationTiming of therapies for Down syndrome: the sooner, the better
Stagni, F., Giacomini, A., Guidi, S., Ciani, E., & Bartesaghi, R. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00265 · Cited by 128
Accortt, E. E., & Wong, M. S. (2017) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000477 · Cited by 122
The clinical manifestations, molecular mechanisms and treatment of craniosynostosis
Stanton, E. W., Urata, M. M., Chen, J.-F., & Chai, Y. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049390 · Cited by 117
Zoëga, H., Kieler, H., Nørgaard, M., Furu, K., Valdimarsdóttir, U. A., Brandt, L., & Haglund, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144474 · Cited by 108
Identification and Management of Peripartum Depression.
Langan, R. C., & Goodbred, A. J. (2016) · PubMed · Cited by 101
Paroxetine—The Antidepressant from Hell? Probably Not, But Caution Required
Nevels, R. M., Gontkovsky, S. T., & Williams, B. E. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4345 · Cited by 95
Masarwa, R., Bar‐Oz, B., Gorelik, E., Reif, S. S., Perlman, A., & Matok, I. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.08.030 · Cited by 106
Millard, S. J., Weston–Green, K., & Newell, K. A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.06.008 · Cited by 83
Stagni, F., Giacomini, A., Emili, M., Trazzi, S., Guidi, S., Sassi, M., Ciani, E., Rimondini, R., & Bartesaghi, R. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.07.031 · Cited by 81
Fumeaux, C. J. F., Harari, M. M., Weisskopf, E., Eap, C. B., Epiney, M., Vial, Y., Csajka, C., Graz, M. B., & Panchaud, A. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2019.1658740 · Cited by 82
Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current Evidence
Alwan, S. S., Friedman, J. M., & Chambers, C. (2016) · CNS Drugs · doi:10.1007/s40263-016-0338-3 · Cited by 80
Self-citationJordan, S. E., Morris, J. K., Davies, G. I., Tucker, D., Thayer, D. S., Luteijn, M., Morgan, M., Garne, E., Hansen, A. V., Klungsøyr, K., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165122 · Cited by 67
Stagni, F., Giacomini, A., Guidi, S., Emili, M., Uguagliati, B., Salvalai, M. E., Bortolotto, V., Grilli, M., Rimondini, R., & Bartesaghi, R. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.08.018 · Cited by 68
Mitchell, J., & Goodman, J. H. (2018) · Archives of Women s Mental Health · doi:10.1007/s00737-018-0844-z · Cited by 61
Luteolin induces hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome
Zhou, W., Miao, Z., Zhang, B., Long, W., Zheng, F., Kong, J., & Yu, B. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.248519 · Cited by 53
Perinatal Mood and Anxiety Disorders
Byrnes, L. (2018) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2018.03.010 · Cited by 51
Andrade, S. E., Reichman, M. E., Mott, K., Pitts, M., Kieswetter, C., Dinatale, M., Stone, M. B., Popovic, J., Haffenreffer, K., & Toh, S. (2016) · Archives of Women's Mental Health · doi:10.1007/s00737-016-0637-1 · Cited by 50
Bajor, L. A., Balsara, C., & Osser, D. N. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114840 · Cited by 43
Given, J. E., Loane, M. A., Garne, E., Nelen, V., Barišić, I., Randrianaivo, H., Khoshnood, B., Wiesel, A., Rißmann, A., Lynch, C., et al. (2017) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12401 · Cited by 43
Prady, S. L., Pickett, K. E., Gilbody, S. M., Petherick, E., Mason, D., Sheldon, T., & Wright, J. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0805-x · Cited by 42
Muzik, M., & Hamilton, S. E. (2016) · Maternal and Child Health Journal · doi:10.1007/s10995-016-2038-5 · Cited by 47
Dawson, A. L., Ailes, E. C., Gilboa, S. M., Simeone, R. M., Lind, J. N., Farr, S. L., Broussard, C. S., Reefhuis, J., Carrino, G., Biermann, J., et al. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6503a1 · Cited by 40
Self-citationPaulzen, M., Goecke, T. W., Stickeler, E., Gründer, G., & Schoretsanitis, G. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.01.019 · Cited by 40
Newborn Brain Function Is Affected by Fetal Exposure to Maternal Serotonin Reuptake Inhibitors
Videman, M., Tokariev, A., Saikkonen, H., Stjerna, S., Heiskala, H. J., Mantere, O., & Vanhatalo, S. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw153 · Cited by 39
Moncrieff, J. (2018) · BJPsych Bulletin · doi:10.1192/bjb.2017.11 · Cited by 40
Sertraline concentrations in pregnant women are steady and the drug transfer to their infants is low
Heinonen, E. W., Blennow, M., Blomdahl-Wetterholm, M., Hovstadius, M., Nasiell, J., Pohanka, A., Gustafsson, L. L., & Wide, K. (2021) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-021-03122-z · Cited by 39
O'Connell, R. V., Dotters-Katz, S. K., Kuller, J. A., & Strauss, R. A. (2016) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000344 · Cited by 38
Ames, J. L., Ladd-Acosta, C., Fallin, M. D., Qian, Y., Schieve, L. A., DiGuiseppi, C., Lee, L.-C., Kasten, E. P., Zhou, G., Pinto-Martin, J., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.04.002 · Cited by 36
Gene/environment interactions in craniosynostosis: A brief review
Durham, E. L., Howie, R. N., & Cray, J. (2017) · Orthodontics and Craniofacial Research · doi:10.1111/ocr.12153 · Cited by 36
Zhang, T., Gao, S., Shen, Z., Li, D., Liu, C., Lv, H., Zhang, Y., Gong, T., Xu, X. P., Ji, C., et al. (2017) · Scientific Reports · doi:10.1038/srep43085 · Cited by 32
Selective serotonin reuptake inhibitors for depression in pregnancy
Susser, L. C., Sansone, S. A., & Hermann, A. D. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.07.011 · Cited by 35
Hansen, C. A., Desrosiers, T. A., Wisniewski, K., Strickland, M. J., Werler, M. M., & Gilboa, S. M. (2020) · Birth Defects Research · doi:10.1002/bdr2.1749 · Cited by 28
Nembhard, W. N., Tang, X., Hu, Z., Macleod, S. L., Stowe, Z. N., Webber, D. M., & Study, T. N. B. D. P. (2017) · BMJ · doi:10.1136/bmj.j832 · Cited by 28
Effect of antidepressants use in pregnancy on foetus development and adverse effects in newborns
Bałkowiec-Iskra, E., Mirowska-Guzel, D. M., & Wielgoś, M. (2017) · Ginekologia Polska · doi:10.5603/gp.a2017.0007 · Cited by 27
Warkus, E. L. L., & Marikawa, Y. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy143 · Cited by 27
Giakoumatos, C. I., & Osser, D. N. (2019) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000197 · Cited by 27
Periconceptional stressors and social support and risk for adverse birth outcomes
Weber, K. A., Carmichael, S. L., Yang, W., Tinker, S. C., Shaw, G. M., & Study, N. B. D. P. (2020) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-020-03182-6 · Cited by 24
A review of key terminology and definitions used for birth defects globally
Malherbe, H. L., Modell, B., Blencowe, H. K., Strong, K., & Aldous, C. R. (2023) · Journal of Community Genetics · doi:10.1007/s12687-023-00642-2 · Cited by 24
Bond, C. M., Johnson, J. C., Chaudhary, V., McCarthy, E. M., McWhorter, M. L., & Woehrle, N. S. (2019) · Brain Research · doi:10.1016/j.brainres.2019.06.001 · Cited by 27
Baldacci, S., Santoro, M. C., Mezzasalma, L., Pierini, A., & Coi, A. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-023-02992-z · Cited by 22
Abejuela, H. R., & Osser, D. N. (2016) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000098 · Cited by 23
Никишин, Д. А., Alyoshina, N. M., Semenova, М. L., & Shmukler, Y. B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20123070 · Cited by 20
Jajoo, A. N., Donlon, C., Shnayder, S., Levin, M. G., & McVey, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-61362-y · Cited by 20
Zuccolo, P. F., Xavier, M. O., Matijasevich, A., Polanczyk, G. V., & Fatori, D. (2021) · Trials · doi:10.1186/s13063-021-05179-8 · Cited by 21
Vuong, H. E., Coley, E. J. L., Kazantsev, M., Cooke, M. E., Rendon, T. K., Paramo, J., & Hsiao, E. Y. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113353 · Cited by 19
Prenatal exposure to antidepressants and risk of epilepsy in childhood
Mao, Y., Pedersen, L. H., Christensen, J., Vestergaard, M., Zhou, W., Olsen, J., & Sun, Y. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4072 · Cited by 19
Centered Partition Processes: Informative Priors for Clustering (with Discussion)
Paganin, S., Herring, A. H., Olshan, A. F., & Dunson, D. B. (2020) · Bayesian Analysis · doi:10.1214/20-ba1197 · Cited by 19
Wu, Z., Zhao, P., Peng, J., Fang, L., Ding, J., Yan, G., Wang, Y., Zhu, J., Wang, D., Li, Y., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.679159 · Cited by 16
Beaulieu, A. M., Tabasky, E., & Osser, D. N. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112583 · Cited by 18
Womersley, K., Ripullone, K., & Agius, M. A. (2017) · PubMed · Cited by 17
Maternal Antibodies to Herpes Virus Antigens and Risk of Gastroschisis in Offspring
Werler, M. M., Parker, S. E., Hedman, K., Gissler, M., Ritvanen, A., & Surcel, H. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kww114 · Cited by 16
Plasticity as a therapeutic target for improving cognition and behavior in Down syndrome
Martínez‐Cué, C., & Dierssen, M. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.11.001 · Cited by 15
Daud, N. A. A., Bergman, J. E. H., Kerstjens‐Frederikse, W. S., Groen, H., & Wilffert, B. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081333 · Cited by 16
Taouk, L. H., Matteson, K. A., Stark, L. M., & Schulkin, J. A. (2017) · Archives of Women s Mental Health · doi:10.1007/s00737-017-0760-7 · Cited by 16
Nielsen, S. W., Ljungdalh, P. S., Nielsen, J., Nørgård, B. M., & Qvist, N. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0667-4 · Cited by 15
Ailes, E. C., Zimmerman, J., Lind, J. N., Fan, F., Shi, K., Reefhuis, J., Broussard, C. S., Frey, M. T., Cragan, J. D., Petersen, E. E., et al. (2020) · Maternal and Child Health Journal · doi:10.1007/s10995-020-02942-2 · Cited by 15
Self-citationPlacental transporter‐mediated drug interactions and offspring congenital anomalies
Ellfolk, M. A., Tornio, A., Niemi, M., Leinonen, M. K., Lahesmaa‐Korpinen, A., & Malm, H. T. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14191 · Cited by 14
A Review of Treatments and Clinical Guidelines for Perinatal Depression
McDonald, M., & Alhusen, J. L. (2022) · The Journal of Perinatal & Neonatal Nursing · doi:10.1097/jpn.0000000000000661 · Cited by 13
Translating molecular advances in Down syndrome and Fragile X syndrome into therapies
Faúndez, V., Toma, I. D., Bardoni, B., Bartesaghi, R., Nižetić, D., de la Torre, R., Kadosh, R. C., Hérault, Y., Dierssen, M., Potier, M., et al. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.03.006 · Cited by 14
The flavonoid 7,8-DHF fosters prenatal brain proliferation potency in a mouse model of Down syndrome
Stagni, F., Uguagliati, B., Emili, M., Giacomini, A., Bartesaghi, R., & Guidi, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-85284-5 · Cited by 13
Sánchez, N., Juárez-Balarezo, J., Olhaberry, M., Oneto, H. G., Muzard, A., Mardonez, M. J., Franco, P., Barrera, F., & Gaete, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.632766 · Cited by 15
Pharmacotherapy of Primary Impulsive Aggression in Violent Criminal Offenders
Felthous, A. R., McCoy, B., Nassif, J., Duggirala, R., Kim, E., Carabellese, F., & Stanford, M. S. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.744061 · Cited by 12
Treating trisomies: Prenatal Down's syndrome therapies explored in mice
Kuehn, B. M. (2016) · Nature Medicine · doi:10.1038/nm0116-6 · Cited by 12
The risks associated with prenatal antidepressant exposure: time for a precision medicine approach
Pedersen, L. H. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1341872 · Cited by 12
A comparison of computational algorithms for the Bayesian analysis of clinical trials
Chen, Z., Berger, J. S., Castellucci, L. A., Farkouh, M. E., Goligher, E. C., Hade, E. M., Hunt, B. J., Kornblith, L. Z., Lawler, P. R., Leifer, E., et al. (2024) · Clinical Trials · doi:10.1177/17407745241247334 · Cited by 11
Cortical Cross-Frequency Coupling Is Affected by in utero Exposure to Antidepressant Medication
Tokariev, A., Oberlander, V. C., Videman, M., & Vanhatalo, S. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.803708 · Cited by 13
Use of prescription medicines in Australian women of child-bearing age
Gadzhanova, S., & Roughead, E. E. (2015) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-015-0033-x · Cited by 10
Reduced Motivation in Perinatal Fluoxetine-Treated Mice: A Hypodopaminergic Phenotype
Menezes, E. D. C., Shah, R., Laughlin, L. C., Vinod, K. Y., Smiley, J. F., Cunha, C., Balla, A., Sershen, H. W., Castellanos, F. X., Corvelo, A., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2608-20.2021 · Cited by 9
Effect of maternal fluoxetine exposure on lung, heart, and kidney development in rat neonates.
Ghavamabadi, R. T., Taghipour, Z., Hassanipour, M., Khademi, M., & Shariati, M. (2018) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2018.27203.6650 · Cited by 9
Wildschut, H. I. J., Duvekot, J. J., Cook, J. R., Bacchus, L. J., Bewley, S., Creighton, S., Dear, J., Williams, D., Kilby, M. D., Crouch, N. S., et al. (2017) · Cambridge University Press eBooks · doi:10.1017/9781108349185 · Cited by 11
Dalke, K. B., Wenzel, A. E., & Kim, D. R. (2016) · Current Psychiatry Reports · doi:10.1007/s11920-016-0698-x · Cited by 13
Kapra, O., Rotem, R. S., & Gross, R. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.555740 · Cited by 10
The Use of Psychotropic Drugs During Pregnancy.
Liu, D., Xu, P., & Jiang, K. (2017) · PubMed Central · doi:10.11919/j.issn.1002-0829.216115 · Cited by 8
Agrawal, P., Singh, P., & Singh, K. P. (2024) · NeuroToxicology · doi:10.1016/j.neuro.2024.10.012 · Cited by 8
PhenCards: a data resource linking human phenotype information to biomedical knowledge
Havrilla, J. M., Liu, C., Dong, X., Weng, C., & Wang, K. (2021) · Genome Medicine · doi:10.1186/s13073-021-00909-8 · Cited by 8
Genetic diagnostic yield in an 11-year cohort of craniosynostosis patients
Gaillard, L., Goverde, A., Weerts, M. J. A., de Klein, A., Mathijssen, I. M. J., & van Dooren, M. F. (2023) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2023.104843 · Cited by 7
Sun, M., Zhang, S., Li, Y., Chen, L., Diao, J., Li, J., Wei, J., Song, X., Liu, Y., Shu, J., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.916882 · Cited by 7
du Plessis, A. J., & Volpe, J. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42876-7.00001-6 · Cited by 7
Medications that Cause Fetal Anomalies and Possible Prevention Strategies
Kiernan, E. A., & Jones, K. L. (2019) · Clinics in Perinatology · doi:10.1016/j.clp.2019.02.003 · Cited by 7
Depression Screening, Diagnosis, and Treatment Across the Lifespan
Cozine, E. W., & Wilkinson, J. M. (2016) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2016.02.004 · Cited by 10
Dolk, H. M., & Wemakor, A. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0099-1 · Cited by 7
Explaining Contemporary Patterns of Cannabis Teratology
Reece, A. S., & Hulse, G. K. (2019) · UWA Profiles and Research Repository (University of Western Australia) · doi:10.4172/2572-0775.1000146 · Cited by 6
Regional variation in gastroschisis: a nationwide database review of demographics and outcomes
Burjonrappa, S. C., & Snyder, A. N. (2021) · Pediatric Surgery International · doi:10.1007/s00383-021-04894-2 · Cited by 6
Tratamento medicamentoso para depressão e prevenção quaternária
Pereira, M. T. C. G., de Souza, F. A. M., & Cardoso, F. M. (2021) · Revista Brasileira de Medicina de Família e Comunidade · doi:10.5712/rbmfc16(43)2568 · Cited by 6
Antidepressant use during pregnancy and risk of congenital heart defects: A case‐time‐control study
Sun, Y., Pedersen, L. H., Wu, C. S., Petersen, I., Sørensen, H. T., & Olsen, J. (2019) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4844 · Cited by 5
Medication use during pregnancy among women with congenital physical disabilities
Garcia, M. H., Petersen, J. M., Parker, S. E., Rubenstein, E., & Werler, M. M. (2022) · Birth Defects Research · doi:10.1002/bdr2.2048 · Cited by 4
The impact of mental health parity laws on birth outcomes
Carney, M. H. (2021) · Health Economics · doi:10.1002/hec.4217 · Cited by 6
Güngör, B. B., Öztürk, N., Atar, A. Ö., & Aydın, N. (2019) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2019.1673936 · Cited by 5
Pharmacological safety during pregnancy: the principles of teratogenesis and teratogenicity of drugs
Reshetko, O. V., Александрович, Л. К., & Klimenchenko, N. I. (2016) · Педиатрическая фармакология · doi:10.15690/pf.v13i2.1551 · Cited by 4
Vaswani, A., Karter, J. M., Cosgrove, L., Peters, S. M., & Brodt, M. (2018) · Women s Reproductive Health · doi:10.1080/23293691.2018.1429532 · Cited by 4
Metadata
- Authors
- Reefhuis, J., Devine, O., Friedman, J. M., Louik, C., & Honein, M. A.
- Affiliations
- Centers for Disease Control and Prevention (US)
- University of British Columbia (CA)
- Boston University (US)
- Corresponding author
- Reefhuis, Jennita
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2015-07-08
- Volume
- 351
- Pages
- h3190
- ISSN
- 1756-1833 (ISSN-L)
- PMC
- PMC4496787
- OpenAlex
- W1930136637
- Cited by
- 161
- References
- 41
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 9 · 2023: 8 · 2022: 10 · 2021: 18 · 2020: 8 · 2019: 19 · 2018: 14 · 2017: 22 · 2016: 29 · 2015: 12
- FWCI
- 3.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- BMJ (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Keywords
- selective serotonin reuptake inhibitors, congenital malformations, paroxetine, fluoxetine, sertraline, citalopram, escitalopram, anencephaly, atrial septal defect, right ventricular outflow tract obstruction, gastroschisis, omphalocele, craniosynostosis, posterior odds ratio
- MeSH terms
- Abnormalities, Drug-Induced, Adult, Bayes Theorem, Depression, Female, Humans, Infant, Newborn, Pregnancy, Pregnancy Complications, Prenatal Exposure Delayed Effects, United States, Odds Ratio, Case-Control Studies, Selective Serotonin Reuptake Inhibitors, Cardiovascular Abnormalities, Gastroschisis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
